NCT05489601View on ClinicalTrials.gov

Non-intrusive Detection of Temporary Neurologic Impairment by Opioids

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

March 29, 2022

Study Completion Date

March 29, 2022

Conditions
Neurologic Impairment by Opioids
Interventions
DRUG

Oxycodone

Oxycodone in 5mg increments up to a maximum of 10mg

Trial Locations (1)

85260

Mayo Clinic, Scottsdale

All Listed Sponsors
lead

Zxerex Corporation

INDUSTRY

NCT05489601 - Non-intrusive Detection of Temporary Neurologic Impairment by Opioids | Biotech Hunter | Biotech Hunter